Reply to Adzemovic et al

Philippa Randall^{1

2

3}, Junior Mutsvangwa⁴, Marriott Nliwasa⁵, Lindsay Wilson^{1

2}, Brandon Reyneke^{1

2}, Beauty Makamure⁴, Edson Makambwa^{1

2}, Richard Meldau^{1

2}, Keertan Dheda^{1

2

6}, Shungu Munyati⁴, Omar Siddiqi^{7

8}, Elizabeth Corbett⁵, Ali Esmail^{1

2}

Affiliations

¹ Centre for Lung Infection and Immunity, Department of Medicine, University of Cape Town, Observatory, Cape Town, South Africa.
² Division of Pulmonology, University of Cape Town Lung Institute, Observatory, Cape Town, South Africa.
³ Antrum Biotech (Pty Ltd), Observatory, Cape Town, South Africa.
⁴ Biomedical Research and Training Institute, Harare, Zimbabwe.
⁵ College of Medicine, University of Malawi, Blantyre, Malawi.
⁶ Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
⁷ Division of Neuro-Virology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
⁸ Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia.

Philippa Randall et al. Open Forum Infect Dis. 2025.

. 2025 May 5;12(5):ofaf271.

doi: 10.1093/ofid/ofaf271. eCollection 2025 May.

¹ Centre for Lung Infection and Immunity, Department of Medicine, University of Cape Town, Observatory, Cape Town, South Africa.
² Division of Pulmonology, University of Cape Town Lung Institute, Observatory, Cape Town, South Africa.
³ Antrum Biotech (Pty Ltd), Observatory, Cape Town, South Africa.
⁴ Biomedical Research and Training Institute, Harare, Zimbabwe.
⁵ College of Medicine, University of Malawi, Blantyre, Malawi.
⁶ Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
⁷ Division of Neuro-Virology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
⁸ Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia.

No abstract available

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts.

1. Randall P, Mutsvangwa J, Nliwasa M, et al. Utility of cerebrospinal fluid unstimulated interferon-gamma (IRISA-TB) as a same-day test for tuberculous meningitis in a tuberculosis-endemic, resource-poor setting. Open Forum Infect Dis 2024; 11:ofae496. - PMC - PubMed
1. Chen X, Wei J, Zhang M, et al. Prevalence, incidence, and case fatality of tuberculous meningitis in adults living with HIV: a systematic review and meta-analysis. BMC Public Health 2024; 24:2145. - PMC - PubMed
1. Theron G, Venter R, Calligaro G, et al. Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results? Clin Infect Dis 2016; 62:995–1001. - PMC - PubMed
1. Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis 2018; 18:76–84. Erratum in: Lancet Infect Dis 2018; 18:376. - PMC - PubMed
1. van Zyl-Smit RN, Pai M, Peprah K, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009; 180:49–58. - PubMed